Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0001493152-21-026386

Options or other derivatives

  • Director acquired 79,192 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Turner Mervyn Director 2021-10-22 Grant or award · Employee Stock Option (right to buy) +69,793 69,793 D: show line 1 in the form
Turner Mervyn Director 2021-10-22 Grant or award · Earnout Rights (Restricted Stock Units) +9,399 9,399 D: show line 2 in the form
Loading xslF345X03/ownership.xml…